Published in Gene Therapy Weekly, November 29th, 1999
Mark Suter and colleagues from institutions in Switzerland, Australia, and The Netherlands, created a novel DNA vaccine combining BAC with a replication-competent, packaging-defective virus genome. Their study results were reported in a recent issue of the Proceedings of the National Academy of Sciences ("BAC-VAC, a Novel Generation of DNA Vaccines: A Bacterial Artificial Chromosome (BAC) Containing a Replication-Competent, Packaging-Defective Virus Genome Induces Protective Immunity against Herpes Simplex Virus 1," PNAS,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.